Department of Health and Human Services Good Guidance Practices, 51396-51401 [2020-18208]
Download as PDF
51396
Federal Register / Vol. 85, No. 162 / Thursday, August 20, 2020 / Proposed Rules
parties must go through notice-andcomment rulemaking. See, e.g., Chrysler
Corp. v. Brown, 441 U.S. 281, 302
45 CFR Part 1
(1979). This is true regardless of
whether agencies frame these rules as
RIN 0991–AC17
sub-regulatory guidance. See, e.g., Iowa
League of Cities v. E.P.A., 711 F.3d 844,
Department of Health and Human
875 (8th Cir. 2013); Gen. Elec. Co. v.
Services Good Guidance Practices
E.P.A., 290 F.3d 377, 385 (D.C. Cir.
AGENCY: Office of the Secretary,
2002). The APA’s procedural
Department of Health and Human
requirements sound in notions of good
Services.
governance. See, e.g., Smiley v.
Citibank, N.A., 517 U.S. 735, 741 (1996).
ACTION: Notice of proposed rulemaking.
Agencies can generally issue
SUMMARY: The Department of Health and interpretive rules and statements of
Human Services proposes to issue
policy without conducting notice-andregulations governing the agency’s
comment rulemaking,1 although such
release and maintenance of guidance
sub-regulatory guidance lacks the force
documents. These regulations would
and effect of law and cannot bind
help to ensure that the public receives
regulated parties. See, e.g., Shalala v.
appropriate notice of new guidance and Guernsey Mem’l Hosp., 514 U.S. 87, 99
that the Department’s guidance does not (1995).
impose obligations on regulated parties
II. Summary of Proposed Good
that are not already reflected in duly
Guidance Practices Regulations
enacted statutes or regulations lawfully
To promote the appropriate issuance
promulgated under them.
and use of guidance documents, and
DATES: To be assured consideration,
consistent with the requirements of
comments must be received at one of
Executive Order 13891 of October 9,
the addresses provided below, no later
than 11:59 p.m. on September 16, 2020. 2019, ‘‘Promoting the Rule of Law
Through Improved Agency Guidance
ADDRESSES: Because of staff and
Documents,’’ 84 FR 55235 (Oct. 15,
resource limitations, we cannot accept
2019), the United States Department of
comments by facsimile (FAX)
Health and Human Services (‘‘HHS’’ or
transmission.
‘‘the Department’’) is proposing to issue
Comments, including mass comment
regulations that set forth good guidance
submissions, must be submitted
practices that would apply to all
electronically at https://
divisions of HHS other than the Food
www.regulations.gov. Follow the
and Drug Administration (‘‘FDA’’). FDA
‘‘Submit a comment’’ instructions.
currently operates under a set of good
For information on viewing public
guidance practices regulations, see 21
comments, see the beginning of the
CFR 10.115, as required by the Federal
SUPPLEMENTARY INFORMATION section.
Food, Drug, and Cosmetic Act, 21 U.S.C.
FOR FURTHER INFORMATION CONTACT:
371(h), but no other division within
Brenna Jenny, Department of Health and HHS operates under a similar set of
Human Services, 200 Independence,
regulations. FDA will also be proposing
Avenue SW, Room 713F, Washington,
amendments to its good guidance
DC 20201. Email: Good.Guidance@
practices regulations, which would
hhs.gov. Telephone: (202) 690–7741.
revise the requirements at 21 CFR
SUPPLEMENTARY INFORMATION:
10.115 to incorporate the directives of
Inspection of Public Comments: All
Executive Order 13891. The
comments received before the close of
requirements in this HHS proposed rule,
the comment period are available for
if finalized, would be promulgated at 45
viewing by the public, including any
CFR part 1, which is currently
personally identifiable or confidential
unassigned.
business information that is included in
This proposed good guidance
a comment. Before or after the close of
practices rule is one component of the
the comment period, the Department of
Department’s broader regulatory reform
Health and Human Services will post all initiative. The proposed rule is designed
timely submitted comments on https://
to increase accountability, improve the
www.regulations.gov. Follow the search fairness of guidance issued by the
instructions on that website to view
Department, guard against unlawful
public comments.
regulation through guidance, and
I. Statutory and Regulatory Background safeguard the important principles
underlying the United States
Subject to certain exceptions, the
administrative law system.
Administrative Procedure Act (‘‘APA’’),
5 U.S.C. 551 et seq., mandates that rules
1 But see Azar v. Allina Health Services, 139 S.
Ct. 1804 (2019).
imposing new obligations on regulated
jbell on DSKJLSW7X2PROD with PROPOSALS
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
15:51 Aug 19, 2020
Jkt 250001
PO 00000
Frm 00029
Fmt 4702
Sfmt 4702
A. Scope (§ 1.1)
HHS proposes that the requirements
to be established pursuant to this
proposed rule would apply to all
guidance documents issued by all
components of the Department, except
for FDA, which has its own good
guidance practices regulations that it is
in the process of amending to conform,
as appropriate, to the requirements of
Executive Order 13891.
B. Definitions (§ 1.2)
Guidance Document
This proposed rule, if finalized,
would apply to guidance documents
(including those deemed ‘‘significant’’)
issued by the Department, other than
guidance documents issued by FDA.
HHS proposes to define ‘‘guidance
document’’ as any Department
statement of general applicability which
is intended to have future effect on the
behavior of regulated parties and which
sets forth a policy on a statutory,
regulatory, or technical or scientific
issue, or an interpretation of a statute or
regulation. The contents of a
transmission, rather than its format,
dictates whether it would constitute a
guidance document; guidance would
not need to be in the form of a formal
written document to constitute a
‘‘guidance document’’ under this
proposed rule. Rather, guidance may
come in a variety of forms, including,
but not limited to, letters, memoranda,
circulars, bulletins, advisories, and
preambles and may include video,
audio, and Web-based formats. See
OMB Bulletin 07–02, ‘‘Agency Good
Guidance Practices,’’ 72 FR 3432, 3434
(January 25, 2007). The hallmark of
guidance is that it includes statements
of general applicability intended to
govern the future behavior of regulated
parties. Thus, agency releases of
technical or scientific information
would not constitute guidance unless
also accompanied by a policy on or
related to that technical or scientific
information that is intended to affect the
future behavior of regulated parties.
This proposed rule would not require
HHS to justify the quality of
information; regulated parties and other
stakeholders should use existing
mechanisms to address the quality of
information contained in documents
issued by HHS. Materials directed at
government employees or agency
contractors, rather than regulated parties
would also not constitute guidance
within the meaning of this proposed
rule. Similarly, most agency statements
communicating news updates about the
agency would not constitute guidance.
Agency statements of specific
E:\FR\FM\20AUP1.SGM
20AUP1
jbell on DSKJLSW7X2PROD with PROPOSALS
Federal Register / Vol. 85, No. 162 / Thursday, August 20, 2020 / Proposed Rules
applicability—such as advisory or legal
opinions directed to particular parties
about circumstance-specific questions;
notices regarding particular locations,
facilities, or products; and
correspondence with individual persons
or entities, including congressional
correspondence or notices of violation—
would also not be ‘‘guidance.’’
Certain categories of documents
would be excluded from the term
guidance document under the proposed
rule: Rules promulgated pursuant to
notice and comment under 5 U.S.C. 553
or similar statutory provisions; rules
exempt from rulemaking requirements
under 5 U.S.C. 553(a); rules of agency
organization, procedure, or practice;
decisions of agency adjudications under
5 U.S.C. 554 or similar statutory
provisions; internal guidance directed to
the Department or other agencies that is
not intended to have substantial future
effect on the behavior of regulated
parties; internal executive branch legal
advice or legal opinions addressed to
executive branch officials; legal briefs
and other court filings; grant
solicitations and awards; or contract
solicitations and awards.
Whether a document would be
exempt as a rule of agency organization,
procedure, or practice is a functional
test. Documents that are designed to
shape the behavior of the Department
would be exempt; documents designed
to shape the behavior of regulated
parties would be considered guidance if
they also set forth a policy on a
statutory, regulatory, or technical or
scientific issue, or an interpretation of a
statute or regulation.
Pre-enforcement rulings, which are
formal written communications
applying the law to a specific set of facts
(as opposed to making statements of
general applicability) would also not
constitute guidance documents under
the proposed rule. Examples include
letter rulings, advisory opinions, and
no-action letters. But material
embedded within an advisory opinion
or similar letter that otherwise satisfies
the definition of ‘‘guidance document’’
would still be guidance for purposes of
this rule. If a document addressed to
specific individuals nonetheless
contains a statement of general
applicability setting forth a relevant
policy or interpretation that is intended
to have future effect by guiding the
conduct of other regulated parties, then
the document would be a guidance
document.
Consistent with its existing
responsibilities, the HHS Office of the
General Counsel (‘‘OGC’’), after
discussing with senior officials within
the Department, would make the legal
VerDate Sep<11>2014
15:51 Aug 19, 2020
Jkt 250001
determination of whether a document is
excluded from the term ‘‘guidance
document’’ and whether a purported
guidance document is, in fact, a
legislative rule that must go through
notice-and-comment rulemaking. OGC
would continue to determine whether
the contents of certain guidance relating
to Medicare should nonetheless go
through notice-and-comment
rulemaking as a result of the Supreme
Court’s decision in Azar v. Allina
Health Services, 139 S. Ct. 1804 (2019).
Such guidance documents would still
need to meet all applicable
requirements in this part.
Significant Guidance Document
HHS proposes to define ‘‘significant
guidance document’’; additional
procedural requirements, as set forth
below, would apply to a significant
guidance document. HHS proposes to
define the term as a guidance document
that is likely to lead to an annual effect
on the economy of $100 million or
more, or adversely affect in a material
way the economy, a sector of the
economy, productivity, competition,
jobs, the environment, public health or
safety, or state, local, or tribal
governments or communities; create a
serious inconsistency or otherwise
interfere with an action taken or
planned by another agency; materially
alter the budgetary impact of
entitlements, grants, user fees, or loan
programs or the rights or obligations of
recipients thereof; or raise novel legal or
policy issues arising out of legal
mandates, the President’s priorities, or
the principles of Executive Order 12866,
‘‘Regulatory Planning and Review.’’ To
calculate whether a guidance document
is likely to have an annual effect on the
economy of $100 million or more, HHS
would be required to assess the benefits,
costs, or transfer impacts imposed by
that guidance document; as part of this
analysis, any benefit, cost or transfer
occurring in any consecutive twelvemonth period would be compared
against the $100 million threshold.
Future cost savings would not be used
to offset upfront costs. In performing
these analyses, HHS would recognize
that guidance documents are not legally
binding and, therefore, not all regulated
parties would necessarily conform their
behavior to the recommendations set
forth in the guidance, and furthermore,
that the benefits, costs, and transfers
may have been accounted for when HHS
issued an underlying regulation, if any.
HHS operates from the principle that
actions imposing significant benefits,
costs, or transfer impacts on regulated
parties must comply with heightened
procedural requirements. However, it
PO 00000
Frm 00030
Fmt 4702
Sfmt 4702
51397
anticipates that only a subset of
guidance documents would satisfy this
proposed rule’s definition of a
significant guidance document. This is
because to qualify as guidance, as
opposed to a legislative rule, a
document must reflect, implement,
interpret, or describe a legal obligation
imposed by a pre-existing, external
source or advise the public
prospectively of the manner in which
the agency intends to exercise a
discretionary power. It is HHS’s
presumption that a guidance document
that HHS deems significant is actually a
legislative rule that must go through
notice-and-comment rulemaking. HHS
shall make all initial decisions as to
whether a guidance document is
significant, and OMB shall make all
final determinations. If a significance
determination requires a legal
conclusion, OMB cannot reach legal
conclusions on behalf of HHS.
Issued
HHS proposes to define ‘‘issued’’ to
mean distribution of information to the
public that HHS initiated or sponsored.
But if a document directed solely to
Department employees must be made
publicly available under law or agency
disclosure policies, for example posted
on an agency website as the result of
multiple requests under the Freedom of
Information Act, the document would
not be considered to be issued under
this proposed rule.
Guidance Repository
HHS proposes to define ‘‘guidance
repository’’ to mean an online electronic
database containing or linking to
guidance documents. It further proposes
that the Department’s primary guidance
repository can link to subsidiary
guidance repositories.
C. Requirements for Department
Issuance and Use of Guidance
Documents (§ 1.3)
The proposed rule reiterates the
application of existing legal principles
to HHS’s guidance: Unless otherwise
authorized by statute, HHS may not
issue any guidance document that
establishes legal obligations not
reflected in duly enacted statutes or
regulations lawfully promulgated under
them, and may not use any guidance
document for purposes of requiring
persons or entities outside HHS to take
any action or to refrain from taking any
action beyond what is already required
by the terms of an applicable statute or
regulation.
The proposed rule would also create
a process for issuing guidance that
formalizes guardrails designed to ensure
E:\FR\FM\20AUP1.SGM
20AUP1
jbell on DSKJLSW7X2PROD with PROPOSALS
51398
Federal Register / Vol. 85, No. 162 / Thursday, August 20, 2020 / Proposed Rules
that guidance documents are
appropriately issued and used. If the
proposed rule is finalized, following the
effective date, each guidance document
issued by HHS, or any of its
components, would be required
specifically to state that it is a
‘‘guidance’’ document and use the
following language, unless the guidance
is authorized by law to be binding: ‘‘The
contents of this document do not have
the force and effect of law and are not
meant to bind the public in any way,
unless specifically incorporated into a
contract. This document is intended
only to provide clarity to the public
regarding existing requirements under
the law.’’ No guidance document issued
by HHS would be able to direct parties
outside the Federal government to take
or refrain from taking action, except
when restating—with citations to
statutes, regulations, or binding judicial
precedent—mandates contained in a
statute or regulation.
HHS proposes to require that each
guidance document issued by it or any
component after the effective date of
this rule, if finalized, must also include
the following information: (1) The
activities to which and the persons to
whom the guidance applies; (2) the date
HHS issued the guidance document; (3)
a unique agency identifier; (4) a
statement indicating whether the
guidance document replaces or revises a
previously issued guidance document
and, if so, identifying the guidance
document that it replaces or revises; (5)
a citation to the statutory provision(s)
and/or regulation(s) (in Code of Federal
Regulations format) that the guidance
document is interpreting or applying;
and (6) a short summary of the subject
matter covered in the guidance
document. For guidance documents
issued before the implementation date
of this rule, HHS would not
retrospectively revise those guidance
documents to include the information
listed in this paragraph. Any guidance
document issued in conjunction with
one or more other agencies would
nonetheless be required to comply with
all requirements that would be
applicable if the guidance document
were issued solely by HHS.
HHS is proposing to apply additional
procedures to significant guidance
documents. Under the proposed rule,
HHS would submit all significant
guidance documents to the Office of
Information and Regulatory Affairs
(OIRA) for review under Executive
Order 12866 prior to issuance.
Significant guidance documents would
be required to comply with applicable
requirements for significant regulatory
actions, as set forth in executive orders,
VerDate Sep<11>2014
15:51 Aug 19, 2020
Jkt 250001
except that only economically
significant guidance documents would
require a separate Regulatory Impact
Analysis. The Secretary, on a nondelegable basis, would have to approve
any significant guidance document
before the Department issues it.
HHS also proposes that, prior to
issuing any significant guidance
document, HHS must also offer a public
notice and comment period of at least
30 days. HHS would be required to
publish a public notice in both the
Federal Register and the guidance
repository. This notice would list the
end of the comment period, provide
information about where the public may
access a copy of the proposed
significant guidance document, and
include how written comments may be
submitted on the proposed significant
guidance document and an internet
website where those comments may be
reviewed by the public. When issuing
the significant guidance document, HHS
would be required to review all
comments received and publish an
easily accessible public response to
major concerns raised. Cf., e.g., City of
Portland, Oregon v. E.P.A., 507 F.3d
706, 715 (DC Cir. 2007).
Under the proposed rule, HHS could
elect not to conduct a comment period
if it were to find that notice and public
comment are impracticable,
unnecessary, or contrary to the public
interest. The Secretary, as the individual
approving the significant guidance
document, would be required to make
this finding, and the significant
guidance document would have to
incorporate the finding and a brief
statement of reasons in support of such
finding. In addition, a significant
guidance document could be exempted
from any other requirement otherwise
applicable to significant guidance
documents if the Secretary of HHS and
the Administrator of OIRA were to agree
that exigency, safety, health, or other
compelling cause warrants the
exemption.
Also under the proposed rule, HHS
would seek from OIRA, as appropriate,
categorical determinations that classes
of guidance presumptively do not
qualify as significant. Any guidance
satisfying such a categorical exemption
presumptively need not comply with
the requirements of § 1.3(b), but would
need to comply with all other
requirements applicable to guidance
documents. OIRA may request to review
guidance documents within a
categorical exemption and may
nonetheless conclude that a guidance
document that is presumptively not
significant is in fact significant.
PO 00000
Frm 00031
Fmt 4702
Sfmt 4702
HHS seeks comments on the proposed
process for issuing guidance documents,
as well as the proposed additional
requirements for issuing significant
guidance documents, including, for
example, whether under this proposed
rule the Secretary should have the
limited authority to delegate approval of
guidance documents to the Deputy
Secretary; whether the Secretary should
be required to approve guidance
documents that fall into a broader or
narrower category than significant
guidance documents prior to
publication; and the process for
soliciting and responding to public
comments.
D. Guidance Repository (§ 1.4)
HHS proposes to make its guidance
documents available to the public
through the internet. The Department
would establish a guidance repository
on its website at www.hhs.gov/guidance.
By November 2, 2020, the Department
would be required to have posted to the
guidance repository all guidance
documents in effect that were issued by
any component of the Department. The
guidance repository would be required
to be fully text searchable.
Under this proposal, any web page in
the guidance repository that contains
guidance documents would clearly
indicate that any guidance document
previously issued by the Department
would no longer be in effect and would
be considered rescinded, if it is not
included in the guidance repository by
November 2, 2020. All web pages in the
guidance repository containing
guidance documents would also state
that the guidance documents contained
therein ‘‘lack the force and effect of law,
except as authorized by law or as
specifically incorporated into a
contract’’ and ‘‘the Department may not
cite, use, or rely on any guidance that
is not posted on the guidance
repository, except to establish historical
facts.’’
If the Department would desire to
reinstate a rescinded guidance
document not posted to the guidance
repository by November 2, 2020, the
Department would be able to do so only
by following all requirements applicable
to newly issued guidance documents.
If this proposed rule is finalized,
guidance documents issued after the
effective date of the final regulation
would be required to comply with all
applicable requirements in section 1.3.
HHS would be required to post a new
or amended guidance document to the
guidance repository within three
business days of the date on which that
guidance document was issued. For
significant guidance documents issued
E:\FR\FM\20AUP1.SGM
20AUP1
Federal Register / Vol. 85, No. 162 / Thursday, August 20, 2020 / Proposed Rules
jbell on DSKJLSW7X2PROD with PROPOSALS
after the effective date of the final
regulation, HHS would be required to
post proposed versions of significant
guidance documents to the guidance
repository as part of the notice-andcomment process. The Department shall
clearly indicate the end of each
significant guidance document’s
comment period and the mechanisms by
which members of the public may
submit comments on the proposed
significant guidance document. The
Department would also be required to
post online all HHS responses to major
public comments.
HHS seeks comments on all proposed
aspects of the guidance repository.
E. Procedure to Petition for Review of
Guidance (§ 1.5)
Regulated parties should have an
opportunity for administrative and
judicial review of whether a guidance
document inappropriately creates new
obligations or is being used by HHS to
create new obligations. Under the
proposed rule, any interested party
would be able to petition HHS to
withdraw or modify any particular
guidance document. Such petitions
would include requests to determine
whether
• A guidance document, no matter
how styled, imposes binding obligations
on parties beyond what is required by
the terms of applicable statutes and/or
regulations.
• An HHS component is using a
guidance document to create additional
legal obligations beyond what is
required by the terms of applicable
statutes and/or regulations.
• HHS is improperly exempting a
guidance document from the procedures
set forth in this proposed rule.
As part of this petition process
proposed under this proposed rule, the
interested party would be able to ask
HHS to remedy the deficiency relating
to the use or contents of the guidance
document by modifying or withdrawing
the guidance document.2
Petitions under this proposed section
would be addressed to HHS in writing.
The guidance repository would include
clear instructions to members of the
public regarding how to petition for
review of guidance, including how such
petitions can be submitted and an HHS
office responsible for coordinating such
requests.
To facilitate transparency and avoid
duplication of work, under the proposed
rule, HHS would publish all responses
2 However, an interested party could not use this
process to seek changes based on the quality of the
information contained in a document; there are
other processes to address the quality of
information contained in HHS issuances.
VerDate Sep<11>2014
15:51 Aug 19, 2020
Jkt 250001
to petitions for guidance review in a
designated section of its online
guidance repository. If HHS were to
receive multiple similar petitions within
a short time period, it would be able to
aggregate those petitions and respond to
them in a single response, so long as all
petitions were responded to within the
appropriate time period. Under the
proposed rule, HHS would respond to
all petitions within 90 business days of
the date on which the petition was
received. The time period to respond
would be suspended if HHS were to
need to request additional information
from the person who submitted the
petition or to consult with other
stakeholders. Under the proposed rule,
HHS’s response to any such petition
would be considered final agency action
reviewable in court, because it would
mark the consummation of HHS’s
decision-making process and legal
consequences flow from the response to
the petition. See, e.g., Appalachian
Power Co. v. E.P.A., 208 F.3d 1015, 1022
(D.C. Cir. 2000). OGC and the
departmental division that authored the
challenged guidance would be
responsible for responding to all
petitions received on the guidance
document.
HHS seeks comments on the proposed
procedure to allow interested parties to
petition the Department.
III. Rulemaking Analyses and Notices
A. Executive Orders 12866 and 13563
Executive Orders 12866 and 13563,
‘‘Improving Regulation and Regulatory
Review,’’ direct agencies to assess all
costs and benefits of available regulatory
alternatives and, if the regulation is
necessary, to select regulatory
approaches that maximize net benefits.
A Regulatory Impact Analysis must be
prepared for major rules with
economically significant effects. The
Department has determined that this
rulemaking is not a significant
regulatory action under these Executive
orders. As such, the Department does
not anticipate that this rulemaking will
impose measurable costs on regulated
parties. This proposed rule describes
proposed agency processes for issuing
guidance and responding to petitions
regarding guidance that allegedly is
inappropriate or is being used
inappropriately. The Department
proposes to adopt these procedures as
part of its regulatory reform initiative.
Implementation of this proposed rule
would require HHS expenditures to
create and maintain the guidance
repository, along with employing a new
process for the review of significant
guidance documents and for the review
PO 00000
Frm 00032
Fmt 4702
Sfmt 4702
51399
of guidance documents which are the
subject of a petition for review. The
Department expects benefits to accrue as
a result of the streamlined and clarified
process of issuing guidance documents,
in addition to positive consequences
flowing from improved agency decision
making. If this proposed rule is
finalized, the Department anticipates
that the public, and, in particular,
regulated parties, would benefit from
greater efficiencies and more
transparency in how the Department
operates and regulates.
B. Executive Order 13771
This proposed rule is expected to be
neither a regulatory nor a deregulatory
action under E.O. 13771, ‘‘Reducing
Regulation and Controlling Regulatory
Costs,’’ because this rule is estimated to
impose no more than de minimis costs
on regulated entities.
C. Regulatory Flexibility Act
The Department has examined the
economic implications of this proposed
rule as required by the Regulatory
Flexibility Act (RFA), 5 U.S.C. 601 et
seq. The RFA requires an agency to
describe the impact of a proposed
rulemaking on small entities by
providing an initial regulatory flexibility
analysis, unless the agency determines
that the proposed rule will not have a
significant impact on a substantial
number of small entities, provides a
factual basis for this determination, and
proposes to certify the statement. 5
U.S.C. 603(a) and 605(b). The
Department considers a proposed or
final rule to have a significant impact on
a substantial number of small entities if
it has at least a three percent impact on
revenue on at least five percent of small
entities. The Department anticipates
that, if finalized, this proposed rule
would allow small entities to operate
more efficiently, by increasing the
transparency of government regulation.
As a result, the Department has
determined, and the Secretary certifies,
that this proposed rule would not have
a significant impact on the operations of
a substantial number of small entities.
D. Executive Order 13132 (Federalism)
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a rule
that imposes substantial direct
requirement costs on State and local
governments or has federalism
implications. The Department has
determined that this proposed rule
would not impose such costs or have
any federalism implications.
E:\FR\FM\20AUP1.SGM
20AUP1
51400
Federal Register / Vol. 85, No. 162 / Thursday, August 20, 2020 / Proposed Rules
E. Paperwork Reduction Act of 1995
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. Ch.
3506; 5 CFR part 1320, appendix A.1),
the Department has reviewed this
proposed rule and has determined that
it proposes no new collections of
information.
List of Subjects in 45 CFR Part 1
Guidance, Reporting and
recordkeeping requirements.
■ For the reasons set forth in the
preamble, the Department of Health and
Human Services proposes to amend 45
CFR, subtitle A, subchapter A, by
adding part 1 to read as follows:
PART 1—GOOD GUIDANCE
PRACTICES
Sec.
1.1 Scope.
1.2 Definitions.
1.3 Requirements for Department issuance
and use of guidance documents.
1.4 Guidance repository.
1.5 Procedure to petition for review of
guidance.
Authority: 42 U.S.C. 1302, 5 U.S.C. 301,
551 et seq.
§ 1.1
Scope.
This part shall apply to guidance
documents issued by all components of
the Department, except the Food and
Drug Administration, for which all
requirements at 21 U.S.C. 371(h) and 21
CFR 10.115 shall continue to apply.
jbell on DSKJLSW7X2PROD with PROPOSALS
§ 1.2
Definitions.
The following definitions apply to
this part. Different definitions may be
found in Federal statutes or regulations
that apply more specifically to
particular programs or activities.
Guidance document means any
Department statement of general
applicability, intended to have future
effect on the behavior of regulated
parties and which sets forth a policy on
a statutory, regulatory, or technical or
scientific issue or an interpretation of a
statute or regulation. The term
‘‘guidance document’’ does not include
rules promulgated pursuant to notice
and comment under 5 U.S.C. 553, or
similar statutory provisions; rules
exempt from rulemaking requirements
under 5 U.S.C. 553(a); rules of agency
organization, procedure, or practice;
decisions of agency adjudications under
5 U.S.C. 554, or similar statutory
provisions; internal guidance directed to
the Department or other agencies that is
not intended to have substantial future
effect on the behavior of regulated
parties; internal executive branch legal
advice or legal opinions addressed to
executive branch officials; legal briefs
VerDate Sep<11>2014
15:51 Aug 19, 2020
Jkt 250001
and other court filings; grant
solicitations and awards; or contract
solicitations and awards. Preenforcement rulings, i.e.,
communications with a person that
interpret or apply the law to a specific
set of facts, such as letter rulings,
advisory opinions, no-action letters, and
notices of noncompliance, do not
constitute guidance documents. If,
however, the Department issues such a
document that on its face is directed to
a particular party, but the content of the
document is designed to guide the
conduct of other regulated parties, such
a document would qualify as guidance.
Guidance repository means an online
database containing or linking to
guidance documents.
Issued means the Department
initiated or sponsored distribution of
information to the public. ‘‘Issued’’ does
not include distribution intended to be
limited to government employees or
agency contractors, or distribution
required under law or agency disclosure
policies.
Significant guidance document means
a guidance document that may
reasonably be anticipated to lead to an
annual effect on the economy of $100
million or more, or adversely affect in
a material way the economy, a sector of
the economy, productivity, competition,
jobs, the environment, public health or
safety, or State, local, or tribal
governments or communities; create a
serious inconsistency or otherwise
interfere with an action taken or
planned by another agency; materially
alter the budgetary impact of
entitlements, grants, user fees, or loan
programs or the rights or obligations of
recipients thereof; or raise novel legal or
policy issues arising out of legal
mandates, the President’s priorities, or
the principles of Executive Order 12866.
The term ‘‘significant guidance
document’’ does not include the
categories of documents exempted in
writing by the Office of Management
and Budget’s (‘‘OMB’’) Office of
Information and Regulatory Affairs
(‘‘OIRA’’).
§ 1.3 Requirements for Department
issuance and use of guidance documents.
(a) Guidance documents. (1) Under
the Administrative Procedure Act, the
Department may not issue any guidance
document that establishes a legal
obligation that is not reflected in a duly
enacted statute or in a regulation
lawfully promulgated under a statute.
(2) The Department may not use any
guidance document for purposes of
requiring a person or entity outside the
Department to take any action, or refrain
from taking any action, beyond what is
PO 00000
Frm 00033
Fmt 4702
Sfmt 4702
required by the terms of an applicable
statute or regulation.
(3) Each guidance document issued by
the Department must:
(i) Identify itself as ‘‘guidance’’ (by
using the term ‘‘guidance’’) and include
the following language, unless the
guidance is authorized by law to be
binding: ‘‘The contents of this document
do not have the force and effect of law
and are not meant to bind the public in
any way, unless specifically
incorporated into a contract. This
document is intended only to provide
clarity to the public regarding existing
requirements under the law.’’;
(ii) Not direct parties outside the
Federal Government to take or refrain
from taking action, except when
restating—with citations to statutes,
regulations, or binding judicial
precedent—clear mandates contained in
a statute or regulation; and
(iii) Include the following
information:
(A) The activities to which and the
persons to whom the document applies;
(B) The date of issuance;
(C) Unique agency identifier;
(D) Whether the guidance document
replaces or revises a previously issued
guidance document and, if so, identify
the guidance document that it replaces
or revises;
(E) Citation to the statutory
provision(s) and/or regulation(s) (in
Code of Federal Regulations format) that
the guidance document is interpreting
or applying; and
(F) A short summary of the subject
matter covered in the guidance
document.
(b) Significant guidance documents.
(1) Before the Department issues any
significant guidance document, it must
be approved, on a non-delegable basis,
by the Secretary.
(2) Before issuing any significant
guidance document, the Department
must:
(i) Submit the significant guidance
document to OIRA for review under
Executive Order 12866 prior to
issuance.
(ii) Provide at least a 30-day public
notice and comment period on the
proposed significant guidance
document, unless the Department for
good cause finds (and incorporates such
finding and a brief statement of reasons
therefor into the guidance document)
that notice and public comment are
impracticable, unnecessary, or contrary
to the public interest. If no such good
cause exists, the public notice (which
must be published in the Federal
Register and posted in the guidance
repository) shall include all of the
following information:
E:\FR\FM\20AUP1.SGM
20AUP1
Federal Register / Vol. 85, No. 162 / Thursday, August 20, 2020 / Proposed Rules
(A) Information as to where the public
may access a copy of the proposed
significant guidance document;
(B) Information as to where written
comments may be sent, and an internet
website where those comments may be
reviewed by the public; and
(C) The time period during which
comments will be accepted.
(iii) Publish a public response to the
major concerns raised during the
comment period.
(3) Significant guidance documents
must comply with applicable
requirements for significant regulatory
actions, as set forth in Executive orders,
except that only economically
significant guidance documents require
a separate Regulatory Impact Analysis.
(4) A significant guidance document
may be exempted from any requirement
otherwise applicable to significant
guidance documents if the Secretary
and the Administrator of OIRA agree
that exigency, safety, health, or other
compelling cause warrants the
exemption. The Secretary must make
this finding, and the significant
guidance document must incorporate
the finding and a brief statement of
reasons in support.
(5) The Department shall seek from
OIRA, as appropriate, categorical
determinations that classes of guidance
presumptively do not qualify as
significant. Any guidance satisfying
such a categorical exemption
presumptively need not comply with
the requirements of this paragraph (b),
but must comply with all other
requirements applicable to guidance
documents. OIRA may determine that a
particular guidance document within a
categorical exemption is nonetheless
significant.
jbell on DSKJLSW7X2PROD with PROPOSALS
§ 1.4
Guidance repository.
(a) Existing guidance. By [date 60
days after effective date of the final rule]
the Department shall maintain a
guidance repository on its website at
www.hhs.gov/guidance.
(1) The guidance repository shall be
fully text searchable and contain or link
to all guidance documents in effect that
have been issued by any component of
the Department.
(2) If the Department does not include
a guidance document in the guidance
repository by November 2, 2020, the
guidance document shall be considered
rescinded.
(3) Any web page in the guidance
repository that contains or links to
guidance documents must state:
(i) That the guidance documents
contained therein:
(A) ‘‘Lack the force and effect of law,
except as authorized by law or as
VerDate Sep<11>2014
15:51 Aug 19, 2020
Jkt 250001
specifically incorporated into a
contract.’’; and
(B) ‘‘The Department may not cite,
use, or rely on any guidance that is not
posted on the guidance repository,
except to establish historical facts.’’
(ii) That any guidance document
previously issued by the Department is
no longer in effect, and will be
considered rescinded, if it is not
included in the guidance repository.
(4) If the Department wishes to
reinstate a rescinded guidance
document, the Department may do so
only by complying with all of the
requirements applicable to guidance
documents issued after [effective date of
the final rule].
(b) Guidance issued after [effective
date of the final rule]. (1) For all
guidance documents issued after
[effective date of the final rule], the
Department must post each guidance
document to the Department’s guidance
repository within three business days of
the date on which that guidance
document was issued.
(2) For significant guidance
documents issued after [effective date of
the final rule], the Department shall post
proposed new significant guidance to
the guidance repository as part of the
notice-and-comment process.
(i) The posting shall clearly indicate
the end of each significant guidance
document’s comment period and
provide a means for members of the
public to submit comments.
(ii) The Department shall also post
online all responses to major public
comments.
§ 1.5 Procedure to petition for review of
guidance.
(a) Any interested party may petition
the Department to withdraw or modify
any particular guidance document. Such
petitions may include requests to
determine whether:
(1) A guidance document, no matter
how styled, imposes binding obligations
on parties beyond what is required by
the terms of applicable statutes and/or
regulations;
(2) A component of the Department is
using a guidance document to create
additional legal obligations beyond
what is required by the terms of
applicable statutes and/or regulations;
or
(3) The Department is improperly
exempting a guidance document from
the requirements set forth in this part.
(b) As part of a petition under this
section, an interested party may ask that
the Department modify or withdraw any
guidance document in effect at the time
of the petition.
(c) Petitions under this section must
be addressed to the Department in
PO 00000
Frm 00034
Fmt 4702
Sfmt 4702
51401
writing. The Department’s guidance
repository must include clear
instructions to members of the public
regarding how to petition for review of
guidance, including how such petition
can be submitted, and an office at the
Department responsible for coordinating
such requests.
(d) The Department must respond to
all petitions no later than 90 business
days after receipt of the petition. The
applicable time period for responding is
suspended from the time the
Department:
(1) Requests additional information
from the requestor, until the Department
receives the additional information; or
(2) Notifies the requestor of the need
to consult with other stakeholders,
including but not limited to the
Department of Justice or the
Department’s Office of Inspector
General, until the Department completes
consultation with other stakeholders.
(e) The Department will publish all
responses to petitions under this section
to a designated web page on its
guidance repository.
Dated: August 14, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2020–18208 Filed 8–17–20; 4:15 pm]
BILLING CODE 4150–26–P
FEDERAL COMMUNICATIONS
COMMISSION
47 CFR Parts 73 and 74
[MB Docket Nos. 19–193, 17–105; Report
No. 3154; FRS 16953]
Petitions for Reconsideration of Action
in Proceeding
Federal Communications
Commission.
ACTION: Petitions for Reconsideration.
AGENCY:
Petitions for Reconsideration
have been filed in the Commission’s
proceeding by Foundation for a
Beautiful Life; and by Todd Urick and
Paul Bame (previously commenting
under ‘‘LPFM/NCE Community-Radio
Engineer Advocates’’ or ‘‘LPFM
Advocates’’), along with Peter Gray
(KFZR–LP), Makeda Dread Cheatom
(KVIB–LP), Brad Johnson (KGIG–LP),
David Stepanyuk (KIEV–LP), and Andy
Hansen-Smith (KCFZ–LP).
DATES: Oppositions to the Petition must
be filed on or before September 4, 2020.
Replies to an opposition must be filed
on or before September 14, 2020.
ADDRESSES: Federal Communications
Commission, 445 12th Street SW,
SUMMARY:
E:\FR\FM\20AUP1.SGM
20AUP1
Agencies
[Federal Register Volume 85, Number 162 (Thursday, August 20, 2020)]
[Proposed Rules]
[Pages 51396-51401]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18208]
[[Page 51396]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
45 CFR Part 1
RIN 0991-AC17
Department of Health and Human Services Good Guidance Practices
AGENCY: Office of the Secretary, Department of Health and Human
Services.
ACTION: Notice of proposed rulemaking.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services proposes to issue
regulations governing the agency's release and maintenance of guidance
documents. These regulations would help to ensure that the public
receives appropriate notice of new guidance and that the Department's
guidance does not impose obligations on regulated parties that are not
already reflected in duly enacted statutes or regulations lawfully
promulgated under them.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 11:59 p.m. on September 16,
2020.
ADDRESSES: Because of staff and resource limitations, we cannot accept
comments by facsimile (FAX) transmission.
Comments, including mass comment submissions, must be submitted
electronically at https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: Brenna Jenny, Department of Health and
Human Services, 200 Independence, Avenue SW, Room 713F, Washington, DC
20201. Email: [email protected]. Telephone: (202) 690-7741.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. Before or after the close of
the comment period, the Department of Health and Human Services will
post all timely submitted comments on https://www.regulations.gov.
Follow the search instructions on that website to view public comments.
I. Statutory and Regulatory Background
Subject to certain exceptions, the Administrative Procedure Act
(``APA''), 5 U.S.C. 551 et seq., mandates that rules imposing new
obligations on regulated parties must go through notice-and-comment
rulemaking. See, e.g., Chrysler Corp. v. Brown, 441 U.S. 281, 302
(1979). This is true regardless of whether agencies frame these rules
as sub-regulatory guidance. See, e.g., Iowa League of Cities v. E.P.A.,
711 F.3d 844, 875 (8th Cir. 2013); Gen. Elec. Co. v. E.P.A., 290 F.3d
377, 385 (D.C. Cir. 2002). The APA's procedural requirements sound in
notions of good governance. See, e.g., Smiley v. Citibank, N.A., 517
U.S. 735, 741 (1996). Agencies can generally issue interpretive rules
and statements of policy without conducting notice-and-comment
rulemaking,\1\ although such sub-regulatory guidance lacks the force
and effect of law and cannot bind regulated parties. See, e.g., Shalala
v. Guernsey Mem'l Hosp., 514 U.S. 87, 99 (1995).
---------------------------------------------------------------------------
\1\ But see Azar v. Allina Health Services, 139 S. Ct. 1804
(2019).
---------------------------------------------------------------------------
II. Summary of Proposed Good Guidance Practices Regulations
To promote the appropriate issuance and use of guidance documents,
and consistent with the requirements of Executive Order 13891 of
October 9, 2019, ``Promoting the Rule of Law Through Improved Agency
Guidance Documents,'' 84 FR 55235 (Oct. 15, 2019), the United States
Department of Health and Human Services (``HHS'' or ``the Department'')
is proposing to issue regulations that set forth good guidance
practices that would apply to all divisions of HHS other than the Food
and Drug Administration (``FDA''). FDA currently operates under a set
of good guidance practices regulations, see 21 CFR 10.115, as required
by the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 371(h), but no
other division within HHS operates under a similar set of regulations.
FDA will also be proposing amendments to its good guidance practices
regulations, which would revise the requirements at 21 CFR 10.115 to
incorporate the directives of Executive Order 13891. The requirements
in this HHS proposed rule, if finalized, would be promulgated at 45 CFR
part 1, which is currently unassigned.
This proposed good guidance practices rule is one component of the
Department's broader regulatory reform initiative. The proposed rule is
designed to increase accountability, improve the fairness of guidance
issued by the Department, guard against unlawful regulation through
guidance, and safeguard the important principles underlying the United
States administrative law system.
A. Scope (Sec. 1.1)
HHS proposes that the requirements to be established pursuant to
this proposed rule would apply to all guidance documents issued by all
components of the Department, except for FDA, which has its own good
guidance practices regulations that it is in the process of amending to
conform, as appropriate, to the requirements of Executive Order 13891.
B. Definitions (Sec. 1.2)
Guidance Document
This proposed rule, if finalized, would apply to guidance documents
(including those deemed ``significant'') issued by the Department,
other than guidance documents issued by FDA. HHS proposes to define
``guidance document'' as any Department statement of general
applicability which is intended to have future effect on the behavior
of regulated parties and which sets forth a policy on a statutory,
regulatory, or technical or scientific issue, or an interpretation of a
statute or regulation. The contents of a transmission, rather than its
format, dictates whether it would constitute a guidance document;
guidance would not need to be in the form of a formal written document
to constitute a ``guidance document'' under this proposed rule. Rather,
guidance may come in a variety of forms, including, but not limited to,
letters, memoranda, circulars, bulletins, advisories, and preambles and
may include video, audio, and Web-based formats. See OMB Bulletin 07-
02, ``Agency Good Guidance Practices,'' 72 FR 3432, 3434 (January 25,
2007). The hallmark of guidance is that it includes statements of
general applicability intended to govern the future behavior of
regulated parties. Thus, agency releases of technical or scientific
information would not constitute guidance unless also accompanied by a
policy on or related to that technical or scientific information that
is intended to affect the future behavior of regulated parties. This
proposed rule would not require HHS to justify the quality of
information; regulated parties and other stakeholders should use
existing mechanisms to address the quality of information contained in
documents issued by HHS. Materials directed at government employees or
agency contractors, rather than regulated parties would also not
constitute guidance within the meaning of this proposed rule.
Similarly, most agency statements communicating news updates about the
agency would not constitute guidance. Agency statements of specific
[[Page 51397]]
applicability--such as advisory or legal opinions directed to
particular parties about circumstance-specific questions; notices
regarding particular locations, facilities, or products; and
correspondence with individual persons or entities, including
congressional correspondence or notices of violation--would also not be
``guidance.''
Certain categories of documents would be excluded from the term
guidance document under the proposed rule: Rules promulgated pursuant
to notice and comment under 5 U.S.C. 553 or similar statutory
provisions; rules exempt from rulemaking requirements under 5 U.S.C.
553(a); rules of agency organization, procedure, or practice; decisions
of agency adjudications under 5 U.S.C. 554 or similar statutory
provisions; internal guidance directed to the Department or other
agencies that is not intended to have substantial future effect on the
behavior of regulated parties; internal executive branch legal advice
or legal opinions addressed to executive branch officials; legal briefs
and other court filings; grant solicitations and awards; or contract
solicitations and awards.
Whether a document would be exempt as a rule of agency
organization, procedure, or practice is a functional test. Documents
that are designed to shape the behavior of the Department would be
exempt; documents designed to shape the behavior of regulated parties
would be considered guidance if they also set forth a policy on a
statutory, regulatory, or technical or scientific issue, or an
interpretation of a statute or regulation.
Pre-enforcement rulings, which are formal written communications
applying the law to a specific set of facts (as opposed to making
statements of general applicability) would also not constitute guidance
documents under the proposed rule. Examples include letter rulings,
advisory opinions, and no-action letters. But material embedded within
an advisory opinion or similar letter that otherwise satisfies the
definition of ``guidance document'' would still be guidance for
purposes of this rule. If a document addressed to specific individuals
nonetheless contains a statement of general applicability setting forth
a relevant policy or interpretation that is intended to have future
effect by guiding the conduct of other regulated parties, then the
document would be a guidance document.
Consistent with its existing responsibilities, the HHS Office of
the General Counsel (``OGC''), after discussing with senior officials
within the Department, would make the legal determination of whether a
document is excluded from the term ``guidance document'' and whether a
purported guidance document is, in fact, a legislative rule that must
go through notice-and-comment rulemaking. OGC would continue to
determine whether the contents of certain guidance relating to Medicare
should nonetheless go through notice-and-comment rulemaking as a result
of the Supreme Court's decision in Azar v. Allina Health Services, 139
S. Ct. 1804 (2019). Such guidance documents would still need to meet
all applicable requirements in this part.
Significant Guidance Document
HHS proposes to define ``significant guidance document'';
additional procedural requirements, as set forth below, would apply to
a significant guidance document. HHS proposes to define the term as a
guidance document that is likely to lead to an annual effect on the
economy of $100 million or more, or adversely affect in a material way
the economy, a sector of the economy, productivity, competition, jobs,
the environment, public health or safety, or state, local, or tribal
governments or communities; create a serious inconsistency or otherwise
interfere with an action taken or planned by another agency; materially
alter the budgetary impact of entitlements, grants, user fees, or loan
programs or the rights or obligations of recipients thereof; or raise
novel legal or policy issues arising out of legal mandates, the
President's priorities, or the principles of Executive Order 12866,
``Regulatory Planning and Review.'' To calculate whether a guidance
document is likely to have an annual effect on the economy of $100
million or more, HHS would be required to assess the benefits, costs,
or transfer impacts imposed by that guidance document; as part of this
analysis, any benefit, cost or transfer occurring in any consecutive
twelve-month period would be compared against the $100 million
threshold. Future cost savings would not be used to offset upfront
costs. In performing these analyses, HHS would recognize that guidance
documents are not legally binding and, therefore, not all regulated
parties would necessarily conform their behavior to the recommendations
set forth in the guidance, and furthermore, that the benefits, costs,
and transfers may have been accounted for when HHS issued an underlying
regulation, if any.
HHS operates from the principle that actions imposing significant
benefits, costs, or transfer impacts on regulated parties must comply
with heightened procedural requirements. However, it anticipates that
only a subset of guidance documents would satisfy this proposed rule's
definition of a significant guidance document. This is because to
qualify as guidance, as opposed to a legislative rule, a document must
reflect, implement, interpret, or describe a legal obligation imposed
by a pre-existing, external source or advise the public prospectively
of the manner in which the agency intends to exercise a discretionary
power. It is HHS's presumption that a guidance document that HHS deems
significant is actually a legislative rule that must go through notice-
and-comment rulemaking. HHS shall make all initial decisions as to
whether a guidance document is significant, and OMB shall make all
final determinations. If a significance determination requires a legal
conclusion, OMB cannot reach legal conclusions on behalf of HHS.
Issued
HHS proposes to define ``issued'' to mean distribution of
information to the public that HHS initiated or sponsored. But if a
document directed solely to Department employees must be made publicly
available under law or agency disclosure policies, for example posted
on an agency website as the result of multiple requests under the
Freedom of Information Act, the document would not be considered to be
issued under this proposed rule.
Guidance Repository
HHS proposes to define ``guidance repository'' to mean an online
electronic database containing or linking to guidance documents. It
further proposes that the Department's primary guidance repository can
link to subsidiary guidance repositories.
C. Requirements for Department Issuance and Use of Guidance Documents
(Sec. 1.3)
The proposed rule reiterates the application of existing legal
principles to HHS's guidance: Unless otherwise authorized by statute,
HHS may not issue any guidance document that establishes legal
obligations not reflected in duly enacted statutes or regulations
lawfully promulgated under them, and may not use any guidance document
for purposes of requiring persons or entities outside HHS to take any
action or to refrain from taking any action beyond what is already
required by the terms of an applicable statute or regulation.
The proposed rule would also create a process for issuing guidance
that formalizes guardrails designed to ensure
[[Page 51398]]
that guidance documents are appropriately issued and used. If the
proposed rule is finalized, following the effective date, each guidance
document issued by HHS, or any of its components, would be required
specifically to state that it is a ``guidance'' document and use the
following language, unless the guidance is authorized by law to be
binding: ``The contents of this document do not have the force and
effect of law and are not meant to bind the public in any way, unless
specifically incorporated into a contract. This document is intended
only to provide clarity to the public regarding existing requirements
under the law.'' No guidance document issued by HHS would be able to
direct parties outside the Federal government to take or refrain from
taking action, except when restating--with citations to statutes,
regulations, or binding judicial precedent--mandates contained in a
statute or regulation.
HHS proposes to require that each guidance document issued by it or
any component after the effective date of this rule, if finalized, must
also include the following information: (1) The activities to which and
the persons to whom the guidance applies; (2) the date HHS issued the
guidance document; (3) a unique agency identifier; (4) a statement
indicating whether the guidance document replaces or revises a
previously issued guidance document and, if so, identifying the
guidance document that it replaces or revises; (5) a citation to the
statutory provision(s) and/or regulation(s) (in Code of Federal
Regulations format) that the guidance document is interpreting or
applying; and (6) a short summary of the subject matter covered in the
guidance document. For guidance documents issued before the
implementation date of this rule, HHS would not retrospectively revise
those guidance documents to include the information listed in this
paragraph. Any guidance document issued in conjunction with one or more
other agencies would nonetheless be required to comply with all
requirements that would be applicable if the guidance document were
issued solely by HHS.
HHS is proposing to apply additional procedures to significant
guidance documents. Under the proposed rule, HHS would submit all
significant guidance documents to the Office of Information and
Regulatory Affairs (OIRA) for review under Executive Order 12866 prior
to issuance. Significant guidance documents would be required to comply
with applicable requirements for significant regulatory actions, as set
forth in executive orders, except that only economically significant
guidance documents would require a separate Regulatory Impact Analysis.
The Secretary, on a non-delegable basis, would have to approve any
significant guidance document before the Department issues it.
HHS also proposes that, prior to issuing any significant guidance
document, HHS must also offer a public notice and comment period of at
least 30 days. HHS would be required to publish a public notice in both
the Federal Register and the guidance repository. This notice would
list the end of the comment period, provide information about where the
public may access a copy of the proposed significant guidance document,
and include how written comments may be submitted on the proposed
significant guidance document and an internet website where those
comments may be reviewed by the public. When issuing the significant
guidance document, HHS would be required to review all comments
received and publish an easily accessible public response to major
concerns raised. Cf., e.g., City of Portland, Oregon v. E.P.A., 507
F.3d 706, 715 (DC Cir. 2007).
Under the proposed rule, HHS could elect not to conduct a comment
period if it were to find that notice and public comment are
impracticable, unnecessary, or contrary to the public interest. The
Secretary, as the individual approving the significant guidance
document, would be required to make this finding, and the significant
guidance document would have to incorporate the finding and a brief
statement of reasons in support of such finding. In addition, a
significant guidance document could be exempted from any other
requirement otherwise applicable to significant guidance documents if
the Secretary of HHS and the Administrator of OIRA were to agree that
exigency, safety, health, or other compelling cause warrants the
exemption.
Also under the proposed rule, HHS would seek from OIRA, as
appropriate, categorical determinations that classes of guidance
presumptively do not qualify as significant. Any guidance satisfying
such a categorical exemption presumptively need not comply with the
requirements of Sec. 1.3(b), but would need to comply with all other
requirements applicable to guidance documents. OIRA may request to
review guidance documents within a categorical exemption and may
nonetheless conclude that a guidance document that is presumptively not
significant is in fact significant.
HHS seeks comments on the proposed process for issuing guidance
documents, as well as the proposed additional requirements for issuing
significant guidance documents, including, for example, whether under
this proposed rule the Secretary should have the limited authority to
delegate approval of guidance documents to the Deputy Secretary;
whether the Secretary should be required to approve guidance documents
that fall into a broader or narrower category than significant guidance
documents prior to publication; and the process for soliciting and
responding to public comments.
D. Guidance Repository (Sec. 1.4)
HHS proposes to make its guidance documents available to the public
through the internet. The Department would establish a guidance
repository on its website at www.hhs.gov/guidance. By November 2, 2020,
the Department would be required to have posted to the guidance
repository all guidance documents in effect that were issued by any
component of the Department. The guidance repository would be required
to be fully text searchable.
Under this proposal, any web page in the guidance repository that
contains guidance documents would clearly indicate that any guidance
document previously issued by the Department would no longer be in
effect and would be considered rescinded, if it is not included in the
guidance repository by November 2, 2020. All web pages in the guidance
repository containing guidance documents would also state that the
guidance documents contained therein ``lack the force and effect of
law, except as authorized by law or as specifically incorporated into a
contract'' and ``the Department may not cite, use, or rely on any
guidance that is not posted on the guidance repository, except to
establish historical facts.''
If the Department would desire to reinstate a rescinded guidance
document not posted to the guidance repository by November 2, 2020, the
Department would be able to do so only by following all requirements
applicable to newly issued guidance documents.
If this proposed rule is finalized, guidance documents issued after
the effective date of the final regulation would be required to comply
with all applicable requirements in section 1.3. HHS would be required
to post a new or amended guidance document to the guidance repository
within three business days of the date on which that guidance document
was issued. For significant guidance documents issued
[[Page 51399]]
after the effective date of the final regulation, HHS would be required
to post proposed versions of significant guidance documents to the
guidance repository as part of the notice-and-comment process. The
Department shall clearly indicate the end of each significant guidance
document's comment period and the mechanisms by which members of the
public may submit comments on the proposed significant guidance
document. The Department would also be required to post online all HHS
responses to major public comments.
HHS seeks comments on all proposed aspects of the guidance
repository.
E. Procedure to Petition for Review of Guidance (Sec. 1.5)
Regulated parties should have an opportunity for administrative and
judicial review of whether a guidance document inappropriately creates
new obligations or is being used by HHS to create new obligations.
Under the proposed rule, any interested party would be able to petition
HHS to withdraw or modify any particular guidance document. Such
petitions would include requests to determine whether
A guidance document, no matter how styled, imposes binding
obligations on parties beyond what is required by the terms of
applicable statutes and/or regulations.
An HHS component is using a guidance document to create
additional legal obligations beyond what is required by the terms of
applicable statutes and/or regulations.
HHS is improperly exempting a guidance document from the
procedures set forth in this proposed rule.
As part of this petition process proposed under this proposed rule,
the interested party would be able to ask HHS to remedy the deficiency
relating to the use or contents of the guidance document by modifying
or withdrawing the guidance document.\2\
---------------------------------------------------------------------------
\2\ However, an interested party could not use this process to
seek changes based on the quality of the information contained in a
document; there are other processes to address the quality of
information contained in HHS issuances.
---------------------------------------------------------------------------
Petitions under this proposed section would be addressed to HHS in
writing. The guidance repository would include clear instructions to
members of the public regarding how to petition for review of guidance,
including how such petitions can be submitted and an HHS office
responsible for coordinating such requests.
To facilitate transparency and avoid duplication of work, under the
proposed rule, HHS would publish all responses to petitions for
guidance review in a designated section of its online guidance
repository. If HHS were to receive multiple similar petitions within a
short time period, it would be able to aggregate those petitions and
respond to them in a single response, so long as all petitions were
responded to within the appropriate time period. Under the proposed
rule, HHS would respond to all petitions within 90 business days of the
date on which the petition was received. The time period to respond
would be suspended if HHS were to need to request additional
information from the person who submitted the petition or to consult
with other stakeholders. Under the proposed rule, HHS's response to any
such petition would be considered final agency action reviewable in
court, because it would mark the consummation of HHS's decision-making
process and legal consequences flow from the response to the petition.
See, e.g., Appalachian Power Co. v. E.P.A., 208 F.3d 1015, 1022 (D.C.
Cir. 2000). OGC and the departmental division that authored the
challenged guidance would be responsible for responding to all
petitions received on the guidance document.
HHS seeks comments on the proposed procedure to allow interested
parties to petition the Department.
III. Rulemaking Analyses and Notices
A. Executive Orders 12866 and 13563
Executive Orders 12866 and 13563, ``Improving Regulation and
Regulatory Review,'' direct agencies to assess all costs and benefits
of available regulatory alternatives and, if the regulation is
necessary, to select regulatory approaches that maximize net benefits.
A Regulatory Impact Analysis must be prepared for major rules with
economically significant effects. The Department has determined that
this rulemaking is not a significant regulatory action under these
Executive orders. As such, the Department does not anticipate that this
rulemaking will impose measurable costs on regulated parties. This
proposed rule describes proposed agency processes for issuing guidance
and responding to petitions regarding guidance that allegedly is
inappropriate or is being used inappropriately. The Department proposes
to adopt these procedures as part of its regulatory reform initiative.
Implementation of this proposed rule would require HHS expenditures to
create and maintain the guidance repository, along with employing a new
process for the review of significant guidance documents and for the
review of guidance documents which are the subject of a petition for
review. The Department expects benefits to accrue as a result of the
streamlined and clarified process of issuing guidance documents, in
addition to positive consequences flowing from improved agency decision
making. If this proposed rule is finalized, the Department anticipates
that the public, and, in particular, regulated parties, would benefit
from greater efficiencies and more transparency in how the Department
operates and regulates.
B. Executive Order 13771
This proposed rule is expected to be neither a regulatory nor a
deregulatory action under E.O. 13771, ``Reducing Regulation and
Controlling Regulatory Costs,'' because this rule is estimated to
impose no more than de minimis costs on regulated entities.
C. Regulatory Flexibility Act
The Department has examined the economic implications of this
proposed rule as required by the Regulatory Flexibility Act (RFA), 5
U.S.C. 601 et seq. The RFA requires an agency to describe the impact of
a proposed rulemaking on small entities by providing an initial
regulatory flexibility analysis, unless the agency determines that the
proposed rule will not have a significant impact on a substantial
number of small entities, provides a factual basis for this
determination, and proposes to certify the statement. 5 U.S.C. 603(a)
and 605(b). The Department considers a proposed or final rule to have a
significant impact on a substantial number of small entities if it has
at least a three percent impact on revenue on at least five percent of
small entities. The Department anticipates that, if finalized, this
proposed rule would allow small entities to operate more efficiently,
by increasing the transparency of government regulation. As a result,
the Department has determined, and the Secretary certifies, that this
proposed rule would not have a significant impact on the operations of
a substantial number of small entities.
D. Executive Order 13132 (Federalism)
Executive Order 13132 establishes certain requirements that an
agency must meet when it promulgates a rule that imposes substantial
direct requirement costs on State and local governments or has
federalism implications. The Department has determined that this
proposed rule would not impose such costs or have any federalism
implications.
[[Page 51400]]
E. Paperwork Reduction Act of 1995
In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C.
Ch. 3506; 5 CFR part 1320, appendix A.1), the Department has reviewed
this proposed rule and has determined that it proposes no new
collections of information.
List of Subjects in 45 CFR Part 1
Guidance, Reporting and recordkeeping requirements.
0
For the reasons set forth in the preamble, the Department of Health and
Human Services proposes to amend 45 CFR, subtitle A, subchapter A, by
adding part 1 to read as follows:
PART 1--GOOD GUIDANCE PRACTICES
Sec.
1.1 Scope.
1.2 Definitions.
1.3 Requirements for Department issuance and use of guidance
documents.
1.4 Guidance repository.
1.5 Procedure to petition for review of guidance.
Authority: 42 U.S.C. 1302, 5 U.S.C. 301, 551 et seq.
Sec. 1.1 Scope.
This part shall apply to guidance documents issued by all
components of the Department, except the Food and Drug Administration,
for which all requirements at 21 U.S.C. 371(h) and 21 CFR 10.115 shall
continue to apply.
Sec. 1.2 Definitions.
The following definitions apply to this part. Different definitions
may be found in Federal statutes or regulations that apply more
specifically to particular programs or activities.
Guidance document means any Department statement of general
applicability, intended to have future effect on the behavior of
regulated parties and which sets forth a policy on a statutory,
regulatory, or technical or scientific issue or an interpretation of a
statute or regulation. The term ``guidance document'' does not include
rules promulgated pursuant to notice and comment under 5 U.S.C. 553, or
similar statutory provisions; rules exempt from rulemaking requirements
under 5 U.S.C. 553(a); rules of agency organization, procedure, or
practice; decisions of agency adjudications under 5 U.S.C. 554, or
similar statutory provisions; internal guidance directed to the
Department or other agencies that is not intended to have substantial
future effect on the behavior of regulated parties; internal executive
branch legal advice or legal opinions addressed to executive branch
officials; legal briefs and other court filings; grant solicitations
and awards; or contract solicitations and awards. Pre-enforcement
rulings, i.e., communications with a person that interpret or apply the
law to a specific set of facts, such as letter rulings, advisory
opinions, no-action letters, and notices of noncompliance, do not
constitute guidance documents. If, however, the Department issues such
a document that on its face is directed to a particular party, but the
content of the document is designed to guide the conduct of other
regulated parties, such a document would qualify as guidance.
Guidance repository means an online database containing or linking
to guidance documents.
Issued means the Department initiated or sponsored distribution of
information to the public. ``Issued'' does not include distribution
intended to be limited to government employees or agency contractors,
or distribution required under law or agency disclosure policies.
Significant guidance document means a guidance document that may
reasonably be anticipated to lead to an annual effect on the economy of
$100 million or more, or adversely affect in a material way the
economy, a sector of the economy, productivity, competition, jobs, the
environment, public health or safety, or State, local, or tribal
governments or communities; create a serious inconsistency or otherwise
interfere with an action taken or planned by another agency; materially
alter the budgetary impact of entitlements, grants, user fees, or loan
programs or the rights or obligations of recipients thereof; or raise
novel legal or policy issues arising out of legal mandates, the
President's priorities, or the principles of Executive Order 12866. The
term ``significant guidance document'' does not include the categories
of documents exempted in writing by the Office of Management and
Budget's (``OMB'') Office of Information and Regulatory Affairs
(``OIRA'').
Sec. 1.3 Requirements for Department issuance and use of guidance
documents.
(a) Guidance documents. (1) Under the Administrative Procedure Act,
the Department may not issue any guidance document that establishes a
legal obligation that is not reflected in a duly enacted statute or in
a regulation lawfully promulgated under a statute.
(2) The Department may not use any guidance document for purposes
of requiring a person or entity outside the Department to take any
action, or refrain from taking any action, beyond what is required by
the terms of an applicable statute or regulation.
(3) Each guidance document issued by the Department must:
(i) Identify itself as ``guidance'' (by using the term
``guidance'') and include the following language, unless the guidance
is authorized by law to be binding: ``The contents of this document do
not have the force and effect of law and are not meant to bind the
public in any way, unless specifically incorporated into a contract.
This document is intended only to provide clarity to the public
regarding existing requirements under the law.'';
(ii) Not direct parties outside the Federal Government to take or
refrain from taking action, except when restating--with citations to
statutes, regulations, or binding judicial precedent--clear mandates
contained in a statute or regulation; and
(iii) Include the following information:
(A) The activities to which and the persons to whom the document
applies;
(B) The date of issuance;
(C) Unique agency identifier;
(D) Whether the guidance document replaces or revises a previously
issued guidance document and, if so, identify the guidance document
that it replaces or revises;
(E) Citation to the statutory provision(s) and/or regulation(s) (in
Code of Federal Regulations format) that the guidance document is
interpreting or applying; and
(F) A short summary of the subject matter covered in the guidance
document.
(b) Significant guidance documents. (1) Before the Department
issues any significant guidance document, it must be approved, on a
non-delegable basis, by the Secretary.
(2) Before issuing any significant guidance document, the
Department must:
(i) Submit the significant guidance document to OIRA for review
under Executive Order 12866 prior to issuance.
(ii) Provide at least a 30-day public notice and comment period on
the proposed significant guidance document, unless the Department for
good cause finds (and incorporates such finding and a brief statement
of reasons therefor into the guidance document) that notice and public
comment are impracticable, unnecessary, or contrary to the public
interest. If no such good cause exists, the public notice (which must
be published in the Federal Register and posted in the guidance
repository) shall include all of the following information:
[[Page 51401]]
(A) Information as to where the public may access a copy of the
proposed significant guidance document;
(B) Information as to where written comments may be sent, and an
internet website where those comments may be reviewed by the public;
and
(C) The time period during which comments will be accepted.
(iii) Publish a public response to the major concerns raised during
the comment period.
(3) Significant guidance documents must comply with applicable
requirements for significant regulatory actions, as set forth in
Executive orders, except that only economically significant guidance
documents require a separate Regulatory Impact Analysis.
(4) A significant guidance document may be exempted from any
requirement otherwise applicable to significant guidance documents if
the Secretary and the Administrator of OIRA agree that exigency,
safety, health, or other compelling cause warrants the exemption. The
Secretary must make this finding, and the significant guidance document
must incorporate the finding and a brief statement of reasons in
support.
(5) The Department shall seek from OIRA, as appropriate,
categorical determinations that classes of guidance presumptively do
not qualify as significant. Any guidance satisfying such a categorical
exemption presumptively need not comply with the requirements of this
paragraph (b), but must comply with all other requirements applicable
to guidance documents. OIRA may determine that a particular guidance
document within a categorical exemption is nonetheless significant.
Sec. 1.4 Guidance repository.
(a) Existing guidance. By [date 60 days after effective date of the
final rule] the Department shall maintain a guidance repository on its
website at www.hhs.gov/guidance.
(1) The guidance repository shall be fully text searchable and
contain or link to all guidance documents in effect that have been
issued by any component of the Department.
(2) If the Department does not include a guidance document in the
guidance repository by November 2, 2020, the guidance document shall be
considered rescinded.
(3) Any web page in the guidance repository that contains or links
to guidance documents must state:
(i) That the guidance documents contained therein:
(A) ``Lack the force and effect of law, except as authorized by law
or as specifically incorporated into a contract.''; and
(B) ``The Department may not cite, use, or rely on any guidance
that is not posted on the guidance repository, except to establish
historical facts.''
(ii) That any guidance document previously issued by the Department
is no longer in effect, and will be considered rescinded, if it is not
included in the guidance repository.
(4) If the Department wishes to reinstate a rescinded guidance
document, the Department may do so only by complying with all of the
requirements applicable to guidance documents issued after [effective
date of the final rule].
(b) Guidance issued after [effective date of the final rule]. (1)
For all guidance documents issued after [effective date of the final
rule], the Department must post each guidance document to the
Department's guidance repository within three business days of the date
on which that guidance document was issued.
(2) For significant guidance documents issued after [effective date
of the final rule], the Department shall post proposed new significant
guidance to the guidance repository as part of the notice-and-comment
process.
(i) The posting shall clearly indicate the end of each significant
guidance document's comment period and provide a means for members of
the public to submit comments.
(ii) The Department shall also post online all responses to major
public comments.
Sec. 1.5 Procedure to petition for review of guidance.
(a) Any interested party may petition the Department to withdraw or
modify any particular guidance document. Such petitions may include
requests to determine whether:
(1) A guidance document, no matter how styled, imposes binding
obligations on parties beyond what is required by the terms of
applicable statutes and/or regulations;
(2) A component of the Department is using a guidance document to
create additional legal obligations beyond what is required by the
terms of applicable statutes and/or regulations; or
(3) The Department is improperly exempting a guidance document from
the requirements set forth in this part.
(b) As part of a petition under this section, an interested party
may ask that the Department modify or withdraw any guidance document in
effect at the time of the petition.
(c) Petitions under this section must be addressed to the
Department in writing. The Department's guidance repository must
include clear instructions to members of the public regarding how to
petition for review of guidance, including how such petition can be
submitted, and an office at the Department responsible for coordinating
such requests.
(d) The Department must respond to all petitions no later than 90
business days after receipt of the petition. The applicable time period
for responding is suspended from the time the Department:
(1) Requests additional information from the requestor, until the
Department receives the additional information; or
(2) Notifies the requestor of the need to consult with other
stakeholders, including but not limited to the Department of Justice or
the Department's Office of Inspector General, until the Department
completes consultation with other stakeholders.
(e) The Department will publish all responses to petitions under
this section to a designated web page on its guidance repository.
Dated: August 14, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2020-18208 Filed 8-17-20; 4:15 pm]
BILLING CODE 4150-26-P